Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Vaccine: X is Scopus-indexed (Q1, CiteScore 4.2), WoS ESCI, DOAJ. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 2590-1362Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Veterinary (all) | 26 / 204 | 87th | Q1 |
| Public Health, Environmental and Occupational Health | 236 / 725 | 67th | Q2 |
| Infectious Diseases | 154 / 361 | 57th | Q2 |
| Immunology and Microbiology (all) | 28 / 63 | 56th | Q2 |
| Molecular Medicine | 122 / 179 | 32nd | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q1, CiteScore 4.2.
Vaccine: X is Q1 in Veterinary (all) (rank 26 of 204), Q2 in Public Health, Environmental and Occupational Health (rank 236 of 725) and Q2 in Infectious Diseases (rank 154 of 361), by CiteScore 2025. It is ranked in 5 subject areas in all.
Vaccine: X is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.2, which places it in quartile Q1 at the 87th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.704, quartile Q1, with an H-index of 27.
The publisher lists an article processing charge of about US$2,440 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Vaccine: X is published by Elsevier Ltd. Its ISSN is 2590-1362.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Vaccine: X has an h-index of 34 and a 2-year mean of 2.48 citations per paper (OpenAlex). Its Scopus CiteScore is 4.2, quartile Q1. On 2-year citations it ranks #22 of 197 Scopus journals in Veterinary (all).
Vaccine: X published 158 papers in 2025; its busiest recent year was 2024 with 169. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from United States (20.2%), China (7.4%) and Japan (6.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.